ESSA Pharma Inc. announced the appointment of Otello Stampacchia, Ph.D., Founder and Managing Director of Omega Funds to the company's Board of Directors. Mr. Stampacchia was appointed pursuant to the terms of a nomination rights agreement between the company and Omega Fund Management, LLC. Dr. Stampacchia founded Omega Funds in 2004 and leads the firm's investor relations and strategic initiatives. He is a member of Omega's investment committee and is also heavily involved in a number of the firm's therapeutic areas of interest, particularly in oncology, rare diseases and inflammatory disorders. Previously, Dr. Stampacchia led life sciences direct investments and diligence for healthcare venture fund investments at AlpInvest Partners, one of the large private equity asset managers worldwide. Dr. Stampacchia currently serves as a Director for Gossamer Bio, Kronos Bio, Median Technologies, and Replimune.